Chemotherapy-induced neutropenia is a major risk factor for infection-related morbidity and mortality and an important dose-limiting toxicity in cancer treatment. The incidence of severe ...

Treating chemotherapy-induced neutropenia. The most common complication of chemotherapeutic treatment of cancer is the development of neutropenia owing to bone marrow damage. Low neutrophil levels ...

Objective: To systematically evaluate the literature to determine whether vancomycin-induced neutropenia is dose- or duration-related and provide clinicians with feasible treatment alternatives.

Halneuron, a NaV 1.7 sodium channel inhibitor, is being tested for chemotherapy-induced neuropathic pain, offering a potential opioid alternative. Previous trials showed Halneuron significantly ...

Late-onset neutropenia (LON) is emerging as a common ... The mechanisms of LON seem to be multifactorial and are related to rituximab-induced B lymphopenia. LON is self-limited in the majority ...